{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:47:45Z","timestamp":1787942865240,"version":"build-2784847793"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:p>Cholestatic liver disease has long been associated with childhood rickets, secondary to impaired absorption of fat-soluble vitamin D. Elevated serum levels of fibroblast growth factor 23 (FGF23), secondary to genetic defects or tumor-induced osteomalacia, causes hypophosphatemic rickets in childhood. We present 2 infants with end-stage liver disease due to biliary atresia (BA) who developed hypophosphatemia with renal phosphate wasting. Serum FGF23 levels were elevated more than 8 times the upper limit of normal, and the older infant showed radiographic evidence of rickets. Both infants required large supplements of phosphate in addition to calcitriol. Following liver transplantation, FGF23 normalized in both patients and phosphate and calcitriol supplementation were discontinued. Immunohistochemistry revealed ectopic overexpression of FGF23 by hepatocytes in the BA liver. These observations highlight a unique cause of hypophosphatemic rickets in childhood and suggest the need for further investigation into the relationship between BA and other cholestatic disorders, and bone metabolism.<\/jats:p>","DOI":"10.1542\/peds.2015-4453","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:07:21Z","timestamp":1469524041000},"source":"Crossref","is-referenced-by-count":27,"title":["Two Case Reports of FGF23-Induced Hypophosphatemia in Childhood Biliary Atresia"],"prefix":"10.1542","volume":"138","author":[{"given":"Halley","family":"Wasserman","sequence":"first","affiliation":[{"name":"Divisions of Endocrinology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chijioke","family":"Ikomi","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar T.","family":"Hafberg","sequence":"additional","affiliation":[{"name":"Gastroenterology, Hepatology, and Nutrition, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Miethke","sequence":"additional","affiliation":[{"name":"Gastroenterology, Hepatology, and Nutrition, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Bove","sequence":"additional","affiliation":[{"name":"Pathology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe F.","family":"Backeljauw","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"issue":"5","key":"2021120904545214500_B1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/adc.54.5.367","article-title":"Serum 25-hydroxy-vitamin D in hepatobiliary disease in infancy.","volume":"54","author":"Kobayashi","year":"1979","journal-title":"Arch Dis Child"},{"issue":"1","key":"2021120904545214500_B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1203\/00006450-199001000-00006","article-title":"Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia.","volume":"27","author":"Heubi","year":"1990","journal-title":"Pediatr Res"},{"issue":"7","key":"2021120904545214500_B3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia.","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2021120904545214500_B4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2218","article-title":"Tumor-induced rickets in a child with a central giant cell granuloma: a case report.","volume":"135","author":"Fern\u00e1ndez-Cooke","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"2021120904545214500_B5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00467-014-2979-0","article-title":"Tumor-associated FGF-23-induced hypophosphatemic rickets in children: a case report and review of the literature.","volume":"30","author":"Burckhardt","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2021120904545214500_B6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bone.2004.08.009","article-title":"Renal phosphate loss in hereditary and acquired disorders of bone mineralization.","volume":"35","author":"Bielesz","year":"2004","journal-title":"Bone"},{"issue":"2","key":"2021120904545214500_B7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000184216","article-title":"Direct measurement of TP\/GFR: a simple and reliable parameter of renal phosphate handling.","volume":"44","author":"Stark","year":"1986","journal-title":"Nephron"},{"issue":"3","key":"2021120904545214500_B8","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia.","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"2021120904545214500_B9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"issue":"20","key":"2021120904545214500_B10","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","article-title":"Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.","volume":"78","author":"Kobayashi","year":"2006","journal-title":"Life Sci"},{"issue":"5","key":"2021120904545214500_B11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","article-title":"Bone as a source of FGF23: regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"issue":"5","key":"2021120904545214500_B12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00424-003-1084-1","article-title":"Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na\/Pi transporter.","volume":"446","author":"Segawa","year":"2003","journal-title":"Pflugers Arch"},{"issue":"3","key":"2021120904545214500_B13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2021120904545214500_B14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women.","volume":"21","author":"Burnett","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2021120904545214500_B15","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo.","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"2021120904545214500_B16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11154-008-9075-3","article-title":"Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation.","volume":"9","author":"Bastepe","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"2021120904545214500_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","article-title":"The expanding family of hypophosphatemic syndromes.","volume":"30","author":"Carpenter","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"2021120904545214500_B18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.","volume":"42","author":"Endo","year":"2008","journal-title":"Bone"},{"issue":"5","key":"2021120904545214500_B19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/jcem-41-5-926","article-title":"Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets.","volume":"41","author":"Hahn","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120904545214500_B20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1210\/endo.143.2.8627","article-title":"Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule.","volume":"143","author":"Zhang","year":"2002","journal-title":"Endocrinology"},{"issue":"6","key":"2021120904545214500_B21","doi-asserted-by":"crossref","first-page":"e66182","DOI":"10.1371\/journal.pone.0066182","article-title":"Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.","volume":"8","author":"Pri\u00e9","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"2021120904545214500_B22","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/SLA.0b013e3181a3e562","article-title":"Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.","volume":"249","author":"Nafidi","year":"2009","journal-title":"Ann Surg"},{"issue":"6","key":"2021120904545214500_B23","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/en.2008-0877","article-title":"Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.","volume":"150","author":"Ichikawa","year":"2009","journal-title":"Endocrinology"},{"issue":"7","key":"2021120904545214500_B24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD.","volume":"7","author":"Munoz Mendoza","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021120904545214500_B25","author":"Ng","year":"2014"},{"key":"2021120904545214500_B26","author":"Lin","year":"1997"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-4453\/1099848\/peds_20154453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-4453\/1099848\/peds_20154453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T21:55:59Z","timestamp":1639086959000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/138\/2\/e20154453\/52488\/Two-Case-Reports-of-FGF23-Induced-Hypophosphatemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,8,1]]},"published-print":{"date-parts":[[2016,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-4453","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,1]]},"article-number":"e20154453"}}